Angella Nzonza

Title: Angella Nzonza: Innovator in Recombinant Novirhabdovirus Technology

Introduction

Angella Nzonza is a prominent inventor based in Ponthierry, France. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant novirhabdoviruses. Her work focuses on creating innovative solutions that can enhance immune responses to specific antigens.

Latest Patents

Angella Nzonza holds a patent for a recombinant novirhabdovirus that serves as an antigen vector. This invention relates to a recombinant novirhabdovirus expressing a chimeric protein. The chimeric protein comprises the sequence of an antigen of interest, flanked at the N-terminus by a signal peptide and at the C-terminus by a polypeptide that includes at least one portion of the transmembrane domain of a rhabdovirus G protein. This recombinant novirhabdovirus can be utilized to induce an immune response to the antigen of interest. She has 1 patent to her name.

Career Highlights

Angella Nzonza is affiliated with the National Institute for Agricultural Research, where she conducts her research and development activities. Her work at this esteemed institution has allowed her to explore various aspects of agricultural biotechnology and its applications.

Collaborations

Angella collaborates with Michel Bremont, a fellow researcher in her field. Their partnership has contributed to advancements in the understanding and application of recombinant novirhabdoviruses.

Conclusion

Angella Nzonza is a trailblazer in the field of biotechnology, with her innovative work on recombinant novirhabdoviruses paving the way for new approaches to immune response induction. Her contributions are significant and continue to impact the scientific community.